Colgate-Palmolive Co (CL)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
- Symbol
- CL
- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Market cap
- $68.71B
- 52 week range
- 74.55 - 99.33
Valuation
- Share price
- $86.19 (close of 2026-10-05)
- P/E (TTM)
- 33.80x
- Price to book
- 121.39x
- Price to free cash flow
- 17.81x
- Enterprise value
- $75.20B
- Book value per share
- $0.71
Price performance
| Period | Change |
|---|---|
| 1 day | +2.29% |
| 5 days | -0.38% |
| 1 month | -2.91% |
| 3 months | -9.40% |
| 6 months | +1.23% |
| Year to date | +9.07% |
| 1 year | +10.50% |
| 3 years | +24.43% |
| 5 years | +15.82% |
| 10 years | +18.12% |
| All time | +4209.50% |
Members of Congress who disclosed CL trades
Kevin Hern · Lisa McClain · Julie Johnson · Rick Larsen · Ritchie Torres · Shelley Moore Capito · Tim Moore
Super investors holding CL
First Eagle Investment (First Eagle Investment Management, LLC) · Ken Griffin (Citadel) · Yacktman Asset Mgmt (Yacktman Asset Management LP) · Ray Dalio (Bridgewater Associates) · Dodge & Cox (Dodge & Cox Funds) · David Katz (Matrix Asset Advisors Inc)
Profitability and growth
- Return on equity
- 584.11%
- Return on invested capital
- 32.87%
- Return on assets
- 13.06%
- Return on capital employed
- 34.88%
- Gross margin
- 60.11%
- Net margin
- 10.46%
- EBITDA margin
- 19.31%
- Revenue growth
- 1.40%
- Net income growth
- -26.20%
- Free cash flow growth
- 2.48%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 5.62%
- Current ratio
- 1.03x
- Net debt to EBITDA
- 1.69x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $20.38B
- Cost of revenue
- $8.13B
- Gross profit
- $12.25B
- EBITDA
- $3.94B
- Net income
- $2.13B
- Earnings per share
- $2.64
- Research and development
- $366.00M
- Shares outstanding
- 808.70M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | $20.38B | $12.25B | $2.13B | $2.64 |
| 2024-12-31 | $20.10B | $12.16B | $2.89B | $3.53 |
| 2023-12-31 | $19.46B | $11.33B | $2.30B | $2.78 |
| 2022-12-31 | $17.97B | $10.25B | $1.78B | $2.13 |
| 2021-12-31 | $17.42B | $10.38B | $2.17B | $2.56 |
| 2020-12-31 | $16.47B | $10.02B | $2.69B | $3.15 |
| 2019-12-31 | $15.69B | $9.32B | $2.37B | $2.76 |
| 2018-12-31 | $15.54B | $9.23B | $2.40B | $2.76 |
| 2017-12-31 | $15.45B | $9.28B | $2.02B | $2.30 |
| 2016-12-31 | $15.20B | $9.12B | $2.44B | $2.74 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 60.11% | 10.46% | 584.11% | 32.87% |
| 2024-12-31 | 60.50% | 14.37% | 531.07% | 42.22% |
| 2023-12-31 | 58.21% | 11.82% | 240.33% | 33.65% |
| 2022-12-31 | 57.04% | 9.93% | 221.46% | 23.65% |
| 2021-12-31 | 59.55% | 12.43% | 223.07% | 32.56% |
| 2020-12-31 | 60.82% | 16.36% | 244.78% | 37.92% |
| 2019-12-31 | 59.42% | 15.08% | 424.19% | 35.20% |
| 2018-12-31 | 59.39% | 15.44% | 1218.27% | 47.86% |
| 2017-12-31 | 60.05% | 13.10% | 832.92% | 45.39% |
| 2016-12-31 | 60.04% | 16.06% | 14358.82% | 53.68% |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $1.29B | $6.87B |
| 2024-12-31 | $1.10B | $7.29B |
| 2023-12-31 | $966.00M | $8.22B |
| 2022-12-31 | $775.00M | $8.74B |
| 2021-12-31 | $832.00M | $7.19B |
| 2020-12-31 | $888.00M | $7.33B |
| 2019-12-31 | $883.00M | $7.33B |
| 2018-12-31 | $726.00M | $6.35B |
| 2017-12-31 | $1.53B | $6.57B |
| 2016-12-31 | $1.31B | $6.52B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | $3.63B | $155.00M |
| 2024-12-31 | $3.55B | $135.00M |
| 2023-12-31 | $3.04B | $122.00M |
| 2022-12-31 | $1.86B | $125.00M |
| 2021-12-31 | $2.76B | $135.00M |
| 2020-12-31 | $3.31B | $107.00M |
| 2019-12-31 | $2.80B | $100.00M |
| 2018-12-31 | $2.62B | $109.00M |
| 2017-12-31 | $2.50B | $127.00M |
| 2016-12-31 | $2.55B | $123.00M |
Dividend history
- Most recent payment
- 2026-07-20
- Paid in the last twelve months
- $2.10
| Payment date | Dividend per share |
|---|---|
| 2026-07-20 | $0.53 |
| 2026-04-20 | $0.53 |
| 2026-01-21 | $0.52 |
| 2025-10-17 | $0.52 |
| 2025-07-18 | $0.52 |
| 2025-04-17 | $0.52 |
| 2025-01-21 | $0.50 |
| 2024-10-18 | $0.50 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-10-30
- Consensus EPS estimate
- $0.92
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-07-31 | Jun/2026 | $0.95 |
| 2026-05-01 | Mar/2026 | $0.95 |
| 2026-01-30 | Dec/2025 | $0.91 |
| 2025-10-31 | Sep/2025 | $0.89 |
| 2025-08-01 | Jun/2025 | $0.89 |
| 2025-04-25 | Mar/2025 | $0.86 |
| 2025-01-31 | Dec/2024 | $0.89 |
| 2024-10-25 | Sep/2024 | $0.88 |
Filings and sources
- Company website
- colgatepalmolive.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Estee Lauder Companies Inc (EL) · Procter & Gamble Co (PG) · Kenvue Inc. (KVUE) · Kimberly-Clark Corp (KMB) · Church & Dwight Co Inc (CHD) · Sprouts Farmers Market, Inc. (SFM) · Albertsons Companies, Inc. (ACI) · Kroger Co (KR)
All Consumer Defensive companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades